Asthma in children has become more prevalent over the last several decades. Treatment options for addressing treatment-resistant, allergic-type severe asthma have advanced in recent years, as research has begun to uncover the pathological processes that underlie asthma phenotypes. In this article, Meyer Kattan, MD, professor of pediatrics at Columbia University and director of the Pediatric Pulmonary Division at New York-Presbyterian/Morgan Stanley Children’s Hospital, discusses state-of-the-art treatments for severe allergic asthma in children and future directions for research.
Your search for mepolizumab returned 61 results
Mepolizumab 100mg/vial; lyophilized pwd for SC inj after reconstitution; or 100mg/mL, 40mg/0.4mL; soln for SC inj; preservative-free.
Pharmacologic treatments for the management of nasal polyps.
The researchers conducted a retrospective cohort study using claims data from the Optum Research Database for 538 patients at least 6 years of age who initiated mepolizumab treatment for asthma between January 2016 and December 2019.
Investigators assessed a real-world pediatric patients with asthma who used biologic therapy to identify their response to prescribed biologics and reasons for discontinuation of therapy as well as to characterize other attributes of this population.
The primary outcome was to compare dupilumab, benralizumab, and mepolizumab in patients with at least 2 pre-index exacerbations.
Trial enrolled children from disadvantaged urban neighborhoods who have exacerbation-prone eosinophilic asthma
What biologic therapies effectively treat airway hyperresponsiveness in asthma, and what do these therapies show about the underlying biology of asthma?
What is the difference in efficacy between mepolizumab and benralizumab, 2 biologics approved for the treatment of severe eosinophilic asthma?
The summary below gives an overview of important additions and changes MPR has made to its drug database through the end of February. The chart below provides highlights of key monograph updates made this month (not an inclusive list). Click on the name of the drugs to view the full monographs on eMPR.com. Key: D=Dosing,…